Baseline neutrophil‐to‐lymphocyte ratio and efficacy of SGLT2 inhibition with empagliflozin on cardiac remodelling

AIMS: The neutrophil‐to‐lymphocyte ratio (NLR) is a marker of systemic inflammation and plays a critical role in the assessment and prognosis in patients with heart failure. The EMPA‐HEART CardioLink‐6 trial demonstrated that patients with type 2 diabetes (T2D) and coronary artery disease (CAD) trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Raj, Moroney, Michael, Hibino, Makoto, Mazer, Cyril David, Connelly, Kim A., Yan, Andrew T., Quan, Adrian, Teoh, Hwee, Verma, Subodh, Puar, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192265/
https://www.ncbi.nlm.nih.gov/pubmed/37038617
http://dx.doi.org/10.1002/ehf2.14351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192265/
https://www.ncbi.nlm.nih.gov/pubmed/37038617
http://dx.doi.org/10.1002/ehf2.14351

Ejemplares similares